These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38228910)

  • 21. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
    Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
    Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broad targeting of triptolide to resistance and sensitization for cancer therapy.
    Hou ZY; Tong XP; Peng YB; Zhang BK; Yan M
    Biomed Pharmacother; 2018 Aug; 104():771-780. PubMed ID: 29807227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
    Reno TA; Kim JY; Raz DJ
    Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.
    Zhao H; Yang Z; Wang X; Zhang X; Wang M; Wang Y; Mei Q; Wang Z
    Exp Mol Med; 2012 Nov; 44(11):633-41. PubMed ID: 22902510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway.
    Yu C; Shan T; Feng A; Li Y; Zhu W; Xie Y; Li N; Li J
    Fitoterapia; 2011 Jun; 82(4):709-15. PubMed ID: 21376787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon.
    Liu Y; Song F; Wu WK; He M; Zhao L; Sun X; Li H; Jiang Y; Yang Y; Peng K
    Cell Biochem Funct; 2012 Jun; 30(4):271-8. PubMed ID: 22315045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma.
    Giroux Leprieur E; Vieira T; Antoine M; Rozensztajn N; Rabbe N; Ruppert AM; Lavole A; Cadranel J; Wislez M
    Clin Lung Cancer; 2016 Jul; 17(4):301-8. PubMed ID: 26762562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway.
    Yang Y; Ye Y; Qiu Q; Xiao Y; Huang M; Shi M; Liang L; Yang X; Xu H
    Int Immunopharmacol; 2016 Dec; 41():8-16. PubMed ID: 27816728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
    Sugano T; Seike M; Noro R; Soeno C; Chiba M; Zou F; Nakamichi S; Nishijima N; Matsumoto M; Miyanaga A; Kubota K; Gemma A
    Mol Cancer Ther; 2015 Nov; 14(11):2433-40. PubMed ID: 26351321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
    Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
    Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.
    Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS
    Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deoxyshikonin inhibits cisplatin resistance of non-small-cell lung cancer cells by repressing Akt-mediated ABCB1 expression and function.
    Zhang S; Wang Y
    J Biochem Mol Toxicol; 2020 Oct; 34(10):e22560. PubMed ID: 32627280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.
    Du J; Chen W; Yang L; Dai J; Guo J; Wu Y; Gong K; Zhang J; Yu N; Xie Z; Xi S
    Sci Rep; 2017 May; 7(1):1899. PubMed ID: 28507311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis.
    Huang Y; Chen Z; Wang Y; Ba X; Huang Y; Shen P; Wang H; Tu S
    Int J Mol Med; 2019 Jul; 44(1):291-300. PubMed ID: 31115521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1.
    Fan GH; Zhu TY; Huang J
    Cell Signal; 2020 Aug; 72():109665. PubMed ID: 32353410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.